Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment

Summary

The main purpose of this study is to evaluate the efficacy and safety of 3 doses of Somatuline Autogel 60mg to control the muscle infiltration and edema, eyelid retraction and extraocular muscular contraction in patients with active thyroid-associated ophthalmopathy of moderate intensity.

Timeline

Start

2006-01

Primary completion

2007-04

Completion

2007-04

Drugs

Indications